이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Morton Toe and Neuromuscular Performance

2026년 5월 8일 업데이트: Nihat Sarıalioğlu, Giresun University

Morton Toe is Associated With Faster Contractile Properties and Superior Reactive Strength in Female Football Players

This cross-sectional observational study investigated whether female football players with Morton toe morphology differ from those with normal foot morphology in neuromuscular contractile properties and kinetic performance characteristics. Morton toe is a congenital foot variation in which the second toe is longer than the first. A total of 47 female football players were classified into two groups based on bilateral foot morphology: Morton foot group (n = 24) and normal foot group (n = 23). Neuromuscular properties of the dominant vastus lateralis muscle were assessed using tensiomyography, and kinetic performance was evaluated through a 40-cm drop jump test on dual force plates. The primary outcomes were contraction time (Tc) and reactive strength index (RSI). Secondary outcomes included relaxation time, delay time, sustain time, maximal displacement, jump height, peak power normalized to body mass, and landing net peak force normalized to body mass. Multiple linear regression models adjusted for age, body mass index, and mean arch index were used to evaluate whether group differences were independent of potential confounders. This study aimed to determine whether Morton toe morphology is associated with distinct neuromuscular and kinetic performance profiles in female athletes.

연구 개요

상세 설명

Morton toe is a congenital foot morphology characterized by a longer second metatarsal relative to the first. Although traditionally regarded as a clinical or orthopedic variation associated with metatarsal stress fractures and balance difficulties, limited evidence from sprinter populations suggests that a longer second toe may be associated with superior athletic performance. However, no previous study has examined whether Morton toe morphology is related to neuromuscular contractile properties assessed via tensiomyography or kinetic performance derived from force plate testing in a controlled group comparison design.

Participants were screened from 97 female football players. Exclusion criteria included BMI outside the 18.5-29.9 range, bilateral arch index outside the 14-29% range, inconsistent bilateral foot morphology, lower-extremity injury within the past 12 months, neurological or orthopedic conditions, performance-affecting pharmacological use, and menstruation on the measurement day. Morton toe classification was based on the palpation method described by Davidson et al. (2007) with a minimal detectable change threshold of ±0.30 mm.

All measurements were conducted during the off-season to minimize training load interference. Testing followed a standardized sequence: foot morphology assessment, tensiomyography of the dominant vastus lateralis at rest, a 15-minute warm-up, and a 40-cm drop jump test. The assessor was blinded to group classification, and statistical analysis was performed by an independent researcher on a coded dataset. Primary outcome variables (Tc and RSI) were determined a priori. Secondary outcomes were corrected for multiple comparisons using the Holm-Bonferroni method. Regression analyses were performed to assess the independence of group effects from age, body mass index, and mean bilateral arch index.

연구 유형

관찰

등록 (실제)

47

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Centre
      • Giresun, Centre, 터키 (Türkiye), 28100
        • Giresun University - Sports Science Faculty

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

예

샘플링 방법

비확률 샘플

연구 인구

Female football players actively competing in organized leagues in Turkey, recruited from multiple teams during the 2025-2026 off-season period. A total of 97 players were initially screened; 47 met all eligibility criteria and were classified into Morton foot (n=24) and normal foot (n=23) groups.

설명

Inclusion Criteria:

  • Active female football players with a valid sports license for the current season
  • Regular participation in training and competitive matches
  • Bilateral Morton toe morphology (Δ ≤ -0.30 mm on both feet) or bilateral normal foot morphology (Δ > +0.30 mm on both feet)
  • Body mass index between 18.5 and 29.9 kg/m²
  • Bilateral arch index between 14% and 29%
  • Voluntary participation with written informed consent

Exclusion Criteria:

  • Serious lower-extremity musculoskeletal injury within the past 12 months
  • Neurological or orthopedic disease affecting measurement procedures
  • Current use of pharmacological products affecting performance
  • Acute pain, injury, or illness on the measurement day
  • Menstruation on the measurement day (self-reported)
  • Inconsistent bilateral foot morphology classification between feet
  • Bilateral arch index below 14% (high arch) or above 29% (low arch)

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

코호트 및 개입

그룹/코호트
Morton Foot Group
Female football players with bilateral Morton toe morphology, defined as a second metatarsal protrusion distance exceeding the first by more than 0.30 mm bilaterally (Δ ≤ -0.30 mm). n = 24.
Normal Foot Group
Female football players with bilateral normal foot morphology, defined as a first metatarsal protrusion distance exceeding the second by more than 0.30 mm bilaterally (Δ > +0.30 mm). n = 23.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Contraction Time (Tc)
기간: Single measurement session
Tensiomyographic contraction time of the dominant vastus lateralis muscle, defined as the time between 10% and 90% of maximal radial displacement (ms).
Single measurement session
Reactive Strength Index (RSI)
기간: Single measurement session
Jump height divided by ground contact time during a 40-cm drop jump test (m/s). The trial with the highest RSI value out of three attempts was selected for analysis.
Single measurement session

2차 결과 측정

결과 측정
측정값 설명
기간
Maximal Displacement (Dm)
기간: Single measurement session
Peak radial displacement of the vastus lateralis muscle belly during tensiomyographic measurement (mm).
Single measurement session
Relaxation Time (Tr)
기간: Single measurement session
Time from 90% to 50% of maximal displacement during the relaxation phase of tensiomyographic measurement (ms).
Single measurement session
Delay Time (Td)
기간: Single measurement session
Time from electrical stimulus onset to 10% of maximal displacement during tensiomyographic measurement (ms).
Single measurement session
Sustain Time (Ts)
기간: Single measurement session
Duration the muscle response remains above 50% of maximal displacement during tensiomyographic measurement (ms).
Single measurement session
Jump Height (JH)
기간: Single measurement session
Vertical jump height calculated from flight time during a 40-cm drop jump test (cm).
Single measurement session
Peak Power Normalized to Body Mass (PPI)
기간: Single measurement session
Peak power output normalized to body mass during a 40-cm drop jump test (W/kg).
Single measurement session
Landing Net Peak Force Normalized to Body Mass (LPF)
기간: Single measurement session
Peak vertical ground reaction force at landing normalized to body mass during a 40-cm drop jump test (N/kg).
Single measurement session

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2026년 1월 10일

기본 완료 (실제)

2026년 3월 15일

연구 완료 (실제)

2026년 3월 15일

연구 등록 날짜

최초 제출

2026년 5월 8일

QC 기준을 충족하는 최초 제출

2026년 5월 8일

처음 게시됨 (실제)

2026년 5월 14일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 5월 14일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 5월 8일

마지막으로 확인됨

2026년 5월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • GRU-SBF-NS-06
  • 10/492 (기타 식별자: Giresun University Social Sciences, Natural Sciences and Engineering Research Ethics Committee)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다